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SBackground: Obesity is a risk factor for increased perioperative morbidity and mortality in surgical patients.
There have been limited studies to correlate the morbidity of lung cancer resection with obesity.
Methods: We performed a retrospective study of patients who underwent surgical resection for lung cancer at
the Medical College of Wisconsin, Milwaukee, from 2006 to 2010. Data on patient demographics, weight, path-
ological findings, and hospital course were abstracted after appropriate institutional review board approval. Peri-
operative morbidity was defined as atrial fibrillation, heart failure, respiratory failure, pulmonary embolism, or
any medical complications arising within 30 days after surgery. The Fisher exact test was used to test the
association between body mass index (BMI) and perioperative morbidities.
Results: Between 2006 and 2010, 320 lung resections were performed for lung cancer. The median age was 67
(interquartile range, 59-75) years, and 185 (57.8%) were females. A total of 121 (37.8%) of patients had a BMI
lower than 25, and 199 (62.18%) patients had a BMI of 25 or higher. The 30-day mortality rate was 1.8% (n¼ 6)
in the whole group; only 2 of these patients had a BMI of 25 or higher. Perioperative morbidity occurred in 28
(23.14%) of patients with a normal BMI and in 47 (23.61%) of patients with a BMI of 25 or higher (P ¼ .54).
Specific morbidities encountered by patients with normal versus BMI of 25 or higher were as follows: atrial
fibrillation, 11 (9.09%) versus 24 (12.06%) (P ¼ .46); pulmonary embolism, 1 (0.83%) versus 3 (1.51%)
(P ¼ 1.0); congestive heart failure, 2 (1.65%) versus 2 (1.01%) (P ¼ .63); renal failure, 4 (3.3%) versus 2
(1.0%) (P ¼ .29); respiratory failure, 12 (9.92%) versus 17 (8.54%) (P ¼ .69); and acute respiratory distress
syndrome, 2 (1.65%) versus 1 (0.50%) (P¼ .55). The median hospital stay was 5 days in the lower BMI group
and 4 days in the BMI of 25 or higher group (P ¼ .52).
Conclusions: Overweight and normal weight patients do not differ significantly in rates of perioperative
morbidities, 30-day mortality, and length of stay. Our study indicates that potential curative surgical resections
can be offered to even significantly overweight patients. (J Thorac Cardiovasc Surg 2013;146:379-84)It is estimated that more than 65% of US residents are over-
weight or obese.1 Obesity is associated with many medical
comorbidities, including hypertension, diabetes, and coro-
nary artery disease.2,3 Its presence has been associated
with an increased risk of cancers, including breast, colon,
endometrium, and kidney.4,5 There is evidence that obese
patients may also be at increased risk of developing lung
cancer regardless of smoking status.5
Obesity is considered a risk factor for poor outcome in
many surgical procedures, including urologic, gynecologic,
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The Journal of Thoracic and Cathis issue remains controversial, because it has not been
consistent with all studies; some studies indicate that in
noncardiac surgery, obesity alone is not a risk factor for
perioperative morbidity and mortality.8-11
Not much is known about the effects of an elevated body
mass index (BMI) on surgical morbidity and mortality after
the resection of lung cancers. However, it is commonly and
widely assumed that obese patients are at higher risk of sur-
gical complications than those who are not obese. Many
studies assessing the outcomes have included obesity as
one variable with little comment on its prognostic signifi-
cance.12,13 Whether higher BMI is associated with worse
outcomes in patients undergoing lung cancer resections
has been poorly studied.14-17 To our knowledge, there have
been only 3 published studies on the subject. In
a retrospective review of 499 patients who underwent
resections for non–small cell lung cancer, a higher BMI
was not associatedwith increased incidence of perioperative
complications, mortality, or length of stay.18 In contrast, 2
retrospective studies have shown no effect on mortality but
a higher incidence of intrathoracic complications.19,20
To further describe the effects of a higher BMI in patients
undergoing resection of lung cancer, we performed a retro-
spective study to assess the impact of obesity onrdiovascular Surgery c Volume 146, Number 2 379
TABLE 1. Baseline characteristics, surgery type, and pathology
Variable BMI<25 BMI>¼25 P value
Characteristics
Sex .632
Female 72 (59.50) 113 (56.78)
Male 49 (40.50) 86 (43.22)
Age, y .96
Median 67 67
Range 25-88 44-85
Surgery type .61
Lobectomy 76 (62.81) 131 (65.83)
Abbreviations and Acronyms
BMI ¼ body mass index
CI ¼ confidence interval
COPD ¼ chronic obstructive pulmonary disease
FEV1 ¼ forced expiratory volume in 1 second
OR ¼ odds ratio
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for lung cancer.Wedge resection 38 (31.40) 61 (30.65)
Pneumonectomy 7 (5.79) 7 (3.52)
Median (range) tumor size, cm 2.3 (0.5-10) 2.4 (0.6-7) .32
Pathology .0817
Adenocarcinoma 52 (16.25) 111 (34.6)
Squamous cell carcinoma 50 (15.62) 57 (17.8)
Large-cell carcinoma 6 (1.8) 13 (4.06)
Mixed type 10 (3.1) 21 (6.5)
Values are given as number (percentage), unless otherwise indicated. BMI, Body mass
index.METHODS
We performed a retrospective study of patients undergoing resection for
lung cancer at The Medical College of Wisconsin, Milwaukee. After ob-
taining appropriate institutional review board approval, data from patients,
who underwent lung cancer resection from January 2006 to December
2010, were abstracted. Resections of lung metastasis or benign tumors
were excluded.
Patient demographics were collected, including age, sex, height, and
weight. Patient variables and outcomes were stratified by BMI into 2
groups: lower than 25 and 25 or higher. Subjects were staged according
to the 2010 American Joint Committee on Cancer staging. Outcomes mea-
sured included mortality within the 30 days of surgery, length of stay, and
in-hospital complications. The in-hospital complications were defined as
atrial fibrillation, heart failure, respiratory failure, pulmonary embolism,
or any medical complications arising within 30 days of surgery. Respira-
tory failurewas defined as any condition of respiratory distress from severe
chronic obstructive pulmonary disease (COPD) or pneumonia that requires
close monitoring, including noninvasive and invasive ventilation.
Patients were admitted on the day of surgery unless they required pre-
operative management of medical comorbidities. One of 3 board-
certified thoracic surgeons performed all the procedures. The prophylaxis
for venous thromboembolism and the management of postoperative pain
was performed as per standard guidelines. The duration of hospital stay
was calculated from the day of surgery until the patient was discharged.
The duration of chest tube was calculated from the day the chest tube
was placed (on the day of surgery) until the tube was taken out, which
may happen even after discharge in cases of an air leak. We defined mor-
tality as any death occurring within 30 days after surgery.
Statistical Analysis
Association for BMI and hospital days was tested using the Wilcoxon
rank sum test and Pearson and Spearman correlation. The Fisher exact
test was used to test the dichotomous association between BMI of 25 or
higher and the presence of perioperative morbidities. Odds ratios (ORs)
are given with 95% exact confidence intervals (CIs). The log-rank test
was used to compare the overall mortality between the groups.
Multivariate logistic regression of factors predicting perioperative mor-
bidities was considered for all types of morbidity combined and for specific
types in which there were more than 25 events. None of these multivariate
models indicate more than a single predictive factor for any of the morbid-
ities considered.
The analysis was performed using SAS, version 9.2 (The SAS Institute,
Cary, NC).FIGURE 1. Body mass index (BMI) distribution as per World Health
Organization classification.RESULTS
Patient Characteristics
Between 2006 and 2010, there were 320 lung resections
for non–small cell lung cancer. The patient baseline380 The Journal of Thoracic and Cardiovascular Surgdemographics are shown in Table 1. The median age was
67 (interquartile range, 59-75) years, and the sample con-
sisted of 135 (44.2%) men and 185 (55.7%) women. The
frequencies of surgical procedures were as follows: wedge
resections, 99 patients (32.7%); lobectomies, 207 patients
(62.9%); and pneumonectomies, 14 patients (4.3%). Ade-
nocarcinoma was the most prevalent histological feature
present (138 patients, 43.9%), followed by squamous cell
carcinoma (107 patients, 31.6%), bronchoalveolar carci-
noma (25 patients, 7.1%), large-cell carcinoma (19 pa-
tients, 5.4%), and others (31 patients, 11.7%). The
median tumor size was 2.3 cm (interquartile range, 1.5-
3.9 cm) and was highest in the pneumonectomy group. Of
14 pneumonectomies, 8 were left sided and the remaining
6 were right sided.
The distribution of patients in different BMI groups is
shown in a histogram in Figure 1. Most patients were over-
weight (124, 38.7%), defined as a BMI between 25 andery c August 2013
TABLE 2. Morbidities during the perioperative period
Morbidity BMI<25 BMI 25 P value
All 28 (8.75) 47 (14.6) .54
Atrial fibrillation 11 (9.09) 24 (12.06) .46
Respiratory failure 12 (9.92) 17 (8.54) .69
Pulmonary embolism 1 (0.83) 3 (1.51) 1.00
CHF exacerbation 2 (1.65) 2 (1.01) .63
Acute respiratory distress
syndrome
2 (1.65) 1 (0.50) .55
Renal failure 4 (3.3) 2 (1.0) .29
30-d Mortality 4 (1.25) 2 (0.62) .29
Values are given as number (percentage). BMI, Body mass index; CHF, congestive
heart failure.
TABLE 4. The 30-day mortality (causes)
Causes BMI Surgery types
Pulmonary embolism/CHF 27.5 Lobectomy
Hypotension/ischemic bowel 24.8 Lobectomy
Renal failure 24.8 Lobectomy
GI bleed 23.1 Lobectomy
Suicide 19.7 Lobectomy
Cerebrovascular accident 25.3 Wedge resection
BMI, Body mass index; CHF, congestive heart failure; GI, gastrointestinal.
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types of surgery performed were similar in 2 groups of
BMI (<25 and>¼25), as shown in Table 1.
Morbidities From Surgery
Themorbidities encountered perioperatively are shown in
Table 2.A total of 62 (19.3%) perioperativemorbiditieswere
encountered in 320 patients, with no significant difference in
the rate of overall and specific morbidities (P> .05 in all
cases) in between the 2 groups. The distributions of these
morbidities between the 2 BMI groups are shown in Table 2.
The median hospital stay in the normal BMI group was 5
days compared with 4 days (P ¼ .52; Table 3) in the higher
BMI group. The median chest tube duration was the same 3
days across both the groups (P ¼ .052; Table 3).
Mortality From Surgery
The mortality rate in our population was 1.8% (n ¼ 6)
(Table 4). The causes of death were different for all of
them, and only 2 of the people who died had a BMI greater
than 25. The overall survival was similar between the 2
groups (P ¼ .46) (Figure 2).
Interpretation of Multivariate Results (Table 5)
Any perioperative morbidity. Forced expiratory volume
in 1 second (FEV1) was the only significant predictor of
morbidity considered overall. For each 10-point decrease
in FEV1, the odds of any sort of morbidity increased by ap-
proximately 14% (95% CI, 2%-25%; P ¼ .0228).
Although COPD was significant in univariate analysis
(P ¼ .0253), COPD was no longer significant in multivari-
ate analysis controlling for FEV1 (P ¼ .2001).
Air leak. Among the factors considered, including a con-
siderable effort to detect nonlinear effects of BMI, theTABLE 3. Hospital and chest tube durations
Variable BMI<25 BMI 25 P value
Median hospital duration, d 5 4 .52
Median chest tube duration, d 3 3 .052
BMI, Body mass index.
The Journal of Thoracic and Caonly significant predictor was BMI lower than 20 versus
BMI of 20 or higher, with the BMI of 20 or higher group
having considerable lower odds of an air-leak morbidity
(OR, 0.26; 95% CI, 0.12-0.58; P ¼ .0011). This effect
was not significant when considering BMI lower than 25
versus BMI of 25 or higher (P ¼ .5035). We consider the
BMI lower than 20 versus 20 or higher result to be a post
hoc test. It is reported for completeness, but it does not re-
late directly to our main result about high BMI and
morbidity.
Atrial fibrillation. No significant predictors were found.
Respiratory failure. COPD was the only significant pre-
dictor of respiratory failuremorbidity on univariate andmul-
tivariate analysis (OR, 4.1; 95% CI, 1.9-9.0; P ¼ .0008).DISCUSSION
To further describe the surgical risks of overweight pa-
tients undergoing resections for lung cancer, we performed
a retrospective, single-institution review. Our series identi-
fied no difference between the morbidities encountered
postsurgically and in mortality between overweight and
normal weight patients. However, there could be small asso-
ciations, which are present, but too weak to be detected.
BMI did not have any effect on the overall and specific peri-
operative morbidities, whether as a linear (continuous)FIGURE 2. Kaplan-Meier survival curve showing no significant differ-
ence in the survival between the 2 groups. BMI, Body mass index.
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TABLE 5. Univariate and multivariate analysis of all and specific perioperative morbidities with different predictors
Outcome Predictors OR (95% CI) Univariate P values Multivariate P values
Any morbidities COPD (Y vs N) 1.85 (1.09-3.15) .0253 .2001
CHF (Y vs N) 0.72 (0.34-1.55) .4614 .1544
Sex (M vs F) 1.02 (0.63-1.63) 1.0000 .9376
Surgery procedure .7887 .6734 (df ¼ 2)
BMI (linear) 0.98 (0.95-1.02) .3095 .3944
BMI (df ¼ 5) .5053 .5687 (df ¼ 5)
BMI25 (25þ vs<25) 0.84 (0.52-1.35) .5405 .5879
BMI20 (20þ vs<20) 0.49 (0.24-1.00) .0513 .0683
FEV1 (per 1-U FEV) 0.98 (0.97-1.00) .0228 .0228
FEV1 (per 10-U FEV) 0.86 (0.75-0.98) .0228 .0228
DLCO (per 1 U) 0.99 (0.98-1.01) .3144 .9945
Age (per y) 1.01 (0.99-1.03) .5367 .7376
Air leak COPD (Y vs N) 1.45 (0.71-2.93) .3382 .3969
CHF (Y vs N) 0.52 (0.15-1.77) .4450 .2800
Sex (M vs F) 1.05 (0.55-1.99) 1.0000 .9461
Surgery procedure .0998 .3295 (df ¼ 2)
BMI (linear) 0.97 (0.92-1.02) .2731 .2731
BMI (df ¼ 5) .0400 *
BMI25 (25þ vs<25) 0.77 (0.40-1.47) .5035 Already in MV model
BMI20 (20þ vs<20) 0.26 (0.12-0.58) .0011 *
FEV1 (per 1-U FEV) 0.99 (0.98-1.01) .4876 .6211
DLCO (per 1 U) 1.00 (0.98-1.01) .5914 .7174
Age (per y) 1.00 (0.97-1.03) .9867 .9402
Atrial fibrillation COPD (Y vs N) 1.15 (0.51-2.57) .8325
CHF (Y vs N) 0.99 (0.33-2.97) 1.0000
Sex (M vs F) 0.98 (0.65-1.47) 1.0000
Surgery procedure .0990 (df ¼ 2)
BMI (linear) 1.01 (0.96-1.06) .6344
BMI (df ¼ 5) .6320
BMI25 (25þ vs<25) 1.37 (0.65-2.91) .4639
BMI20 (20þ vs<20) 0.88 (0.29-2.66) .8181
FEV1 (per 1-Unit FEV) 0.99 (0.97-1.01) .2530
DLCO (per 1 U) 1.00 (0.98-1.02) .7790
Age (per y) 1.02 (0.98-1.05) .3862
Respiratory failure COPD (Y vs N) 4.13 (1.89-9.01) .0008 .0008
CHF (Y vs N) 1.25 (0.41-3.82) .7589 .7104
Sex (M vs F) 1.31 (0.61-2.82) .5558 .5659
Surgery procedure .7809 .7068
BMI (linear) 0.98 (0.93-1.05) .6122 .8222
BMI (df ¼ 5) .8557 .8630
BMI25 (25þ vs<25) 0.85 (0.39-1.84) .6917 .8794
FEV1 (per 1-U FEV) 0.98 (0.96-1.00) .1095 .7572
DLCO (per 1 U) 1.00 (0.98-1.03) .7444 .1751
Age (per y) 1.01 (0.97-1.05) .6074 .8353
Multivariate analysis not performed for atrial fibrillation because there are no significant predictors. OR, Odds ratio; CI, confidence interval; COPD, chronic obstructive pulmo-
nary disease; Y, yes; N, no; CHF, congestive heart failure; M, male; F, female; DLCO, diffusing capacity for carbon monoxide; MV, multivariate; BMI, body mass index; FEV,
forced expiratory volume. *Only in place of BMI25.
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(Table 5). Our analysis also divided BMI into 4 different
groups as per World Health Organization classification,
with no significant difference in the overall morbidities in
these groups except for the air leak, which tends to occur
more in the lower BMI groups (Table 5).
In the logistic regression model considering any
perioperative morbidity, after controlling for FEV1382 The Journal of Thoracic and Cardiovascular Surg(P ¼ .0228), continuous BMI is not significant
(P¼ .3944). Receiver operating characteristic (curve) plots
show no difference in the model, including both FEV1 and
BMI, compared with FEV1 alone. There is no indication
that BMI at any cut point would add significant predictive
power.
In the logistic regression model considering air leak, con-
tinuous BMI is not significant (P ¼ .2731). The receiverery c August 2013
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sum of sensitivity and specificity at approximately 24 to 25
BMI, but there is no significant predictive power (Figure 3).
The duration of hospital stay is determined by many fac-
tors, such as wound healing, comorbidities, and physical de-
conditioning from surgery. Our study suggests that a higher
BMI does not have any effect on the duration of hospital
stay, because the median length of hospital stay was the
same between the 2 groups. The median chest tube duration
was 3 days in both the groups; however, because of the
higher incidence of outliers in the nonobese groups, the
P value approached the level of significance. This should
be interpreted with caution because this number is highly
influenced by a few patients with a high value of chest
tube days, and is not adjusted for multiple comparisons.
Length of stay and even chest tube duration are influenced
bymany factors, including surgeon preference, variable dis-
charge criteria, and varying protocols for chest tube man-
agement, along with other social factors.
The outcome of our study is similar to the study by Smith
et al,18 in which no difference in overall morbidity, mortal-
ity, and length of stay was found. The mortality rate in their
studywas 1.4%, slightly lower than our 1.8%mortality rate,
but both were within the accepted standards. In the study by
Smith et al, the patients were divided into 2 groups of BMI
(<30 and 30). Our study is different from that because
we divided our patients into 2 groups, with a cutoff BMI
of 25, because we decided to study the risks of overweightFIGURE 3. Receiver operating characteristic (ROC) curve for model,
body mass index (BMI), and forced expiratory volume in 1 second (FEV1).
The Journal of Thoracic and Capopulation versus those who have a normal BMI. Analysis
of our data using the cutoffs used by Smith et al did not
change our results. In the same study, it was shown that
obese patients were at higher risk of developing renal failure
(0.3% vs 3.9%;P¼ .001). However, this was not confirmed
in our series. They also showed a decreased tendency for re-
spiratory complications in obese patients (21.8% vs 14.2%;
P¼ .06 on bivariate analysis) because of higher diffusing ca-
pacity for carbon monoxide and low smoking rates in obese
patients. Our study showed the opposite trend, because there
was no significant difference in respiratory complications
when compared with patients with a normal BMI (9.94%
vs 8.54%; P¼ .69). FEV1 was the only significant predictor
of morbidity considered overall.
In contrast, another study by Petrella et al20 showed that
overweight and obese patients who underwent pneumonec-
tomies for lung cancer had a higher risk of respiratory com-
plications compared with patients with a normal BMI
(21.4% vs 4.9%; P ¼ .005). The study, however, did not
show any difference in cardiac complications, 30-day mor-
tality, and length of stay between the 2 groups.20 Our study
was not limited to pneumonectomies; only 14 patients with
such a procedure were included as part of our cohort. No
differences in outcomes between normal and overweight
patients were seen in this subgroup in our series.
Our study is limited by its retrospective nature; it is pos-
sible that selection bias is responsible for our findings. The
sample size is also small in our study to detect the meaning-
ful differences between the 2 groups. We also did not take
into account the other factors that can affect the morbidity
and mortality, such as diabetes, hypertension, and underly-
ing lung disease, among others, and it was limited to COPD
and congestive heart failure only. Moreover, in our series,
the sample size is even smaller when we use a higher
BMI (>35) to see if the differences exist. We also did not
examine the baseline nutritional status of our patients,
such as prealbumin/albumin, which might influence the
overall outcome. Our study did not examine the outcomes
with minimal invasive surgery and the extent of resection.
In our multivariate analysis, we took into account the 3 ma-
jor types of surgery and found no difference in outcomes
with the types of surgery. Over a 5-year period, the changing
approach for lung resection would have influenced the peri-
operative outcomes and our study was limited to that aspect.
Large multi-institutional and prospective studies are needed
to fully elucidate the effects of higher BMI because of sev-
eral limitations of our retrospective study.
Because of the changing lifestyles, both BMI and lung
cancer are increasing. In the future, thoracic surgeons are
likely to encounter more patients with a higher BMI with
non–small cell lung cancer. Our study suggests that a higher
BMI does not carry significant risk for lung cancer surgery.
However, large, multi-institutional, and prospective studies
are needed to support this evidence.rdiovascular Surgery c Volume 146, Number 2 383
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